Further excitement lies ahead with Novartis Vision trial result to be disclosed this coming weekend. Similar mOS would make Lupin nothing short of outstanding.
Ann: New Independent Trial Data Supports Potential of Veyonda, page-2
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.0¢ | 11.0¢ | $27.98K | 242.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 144057 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 140373 | 2 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |